Visceral adipose tissue specific persistence of Mycobacterium tuberculosis may be reason for the metabolic syndrome

Medical Hypotheses

Volumn 71, Issue 2, 2008, Pages 222-228

  Erol, Adnan ^a  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CARBON; FATTY ACID; GLYOXYLIC ACID; INSULIN; ISOCITRATE LYASE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; BACILLI; BACTEREMIA; BACTERIAL GROWTH; BACTERIAL VIRULENCE; ENZYME INHIBITION; FATTY ACID METABOLISM; HUMAN; IMMUNOSTIMULATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MACROPHAGE; METABOLIC SYNDROME X; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS;

ADIPOSE TISSUE; CHEMOKINE CCL2; DENDRITIC CELLS; GLUCOSE; GLYOXYLATES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INSULIN RESISTANCE; LIVER; MACROPHAGES; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

BACILLI (CLASS); MYCOBACTERIUM TUBERCULOSIS;

EID: 45649083623     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.03.028     Document Type: Article

References (43)

1. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 282 (1999) 677-686
2. Haffner S.M. Abdominal adiposity and cardiometabolic risk: do we have all the answers?. Am J Med 120 Suppl. (2007) S16-S17
3. Cameron A.J., Shaw J.E., and Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33 (2004) 351-375
4. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28 (2005) 2745-2749
5. Erol A. Adipobiology-based pharmacology. Biomed Rev 17 (2006) 73-87
6. McKinney J.D., zu Bentrup K.H., Muñoz-Bias E.J., Miczak A., Chen B., Chan W.-T., et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 496 (2000) 735-738
7. Muñoz-Elias E.J., and McKinney J.D. Carbon metabolism of intracellular bacteria. Cell Microbiol 8 (2006) 10-22
8. Smith C.V., Huang C.C., Miczak A., Russel D.G., Sacchettini J.C., and Höner zu Bentrup K. Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis. J Biol Chem 278 (2003) 1735-1743
9. Monack D.M., Mueller A., and Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2 (2004) 747-765
10. Schaible U.E., and Kaufmann S.H.E. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 4 5 (2007) e115 May
11. Cegielski J.P., and McMurray D.N. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 8 (2004) 286-298
12. Schwenk A., Hodgson L., Rayner C.F., Griffin G.E., and Macallan D.C. Leptin and energy metabolism in pulmonary tuberculosis. Am J Clin Nutr 77 (2003) 392-398
13. Lehninger A.L., Nelson D.L., and Cox M.M. Principles of biochemistry. 4th ed. (2004), W.H. Freeman & Co p. 623-26
14. LaPorte D.C., Walsh K., and Koshland D.E. The branch point effect. Ultrasensitivity and subsensitivity to metabolic control. J Biol Chem 259 (1984) 14068-14075
15. Masters C. Gluconeogenesis and peroxisome. Mol Cell Biochem 166 (1977) 159-168
16. van Eyk A.D., Litthauer D., and Oelofsen W. Mitochondrial and peroxisomal fractions derived from human white adipocytes. Int J Biochem 25 (1993) 1757-1764
17. Thelander M., Fredriksson D., Schouten J., Hoqe J.H., and Ronne H. Cloning by pathway activation in yeast: identification of an Arabidopsis thaliana F-box protein that can turn on glucose repression. Plant Mol Biol 49 (2002) 69-79
18. Lorenz M.C., and Fink G.R. Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryote Cell (2002) 657-662
19. Song S. Can the glyoxylate pathway contribute to fat-induced hepatic insulin resistance?. Med Hypotheses 54 (2000) 739-747
20. Rohde K., Yates R.M., Purdy G.E., and Russell D.G. Mycobacterium and environment within the phagosome. Immunol Rev 219 (2007) 37-54
21. Karakousis P.C., Bishai W.R., and Dorman S.E. Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol 6 (2004) 105-116
22. Riley L.W. Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope lipids and pathogenesis. J Clin Invest 116 (2006) 1475-1478
23. Boshoff H.I.M., and Barry C.E. Tuberculosis-metabolism and respiration in the absence of growth. Nat Rev Microbiol 3 (2005) 70-80
24. Muñoz-Elías E.J., and McKinney J.D. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nature 11 (2005) 638-644
25. Sharma V., Sharma S., Hoener zu Bentrup K., McKinney J.D., Russel D.G., Jacobs Jr. W.R., et al. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Biol 7 (2000) 663-668
26. Desruisseaux M.S., Naqajyothi, Trujillo M.E., Tanowitz H.B., and Scherer P.E. Adipocyte, adipose tissue, and infectious disease. Infect Immun 75 (2007) 1066-1078
27. Neyrolles O., Hernández-Pando R., Pietri-Rouxel F., Fornès P., Tailleux L., et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence?. PLoS One 1 1 (2006) e43 10.1371/journal.pone.0000043
28. Garton N.J., Christensen H., Minnikin D.E., Adegbola R.A., and Barer M.R. Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. Microbiology 148 (2002) 2951-2958
29. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
30. Fontana L., Eagon J.C., Trujillo M.E., Scherer P.E., and Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56 (2007) 1010-1013
31. Lin Y., Berg A.H., Iyengar P., Lam T.K., Giacca A., Combs T.P., et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 280 (2005) 4617-4626
32. Mohammed-Ali V., Goodrick S.J., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., et al. Subcutaneous adipose tissue releases interleukin-6 but not tumor necrosis factor-alpha in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
33. Bruun J.M., Lihn A.S., Pedersen S., and Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90 (2006) 2282-2289
34. Lumeng C.N., Deyoung S.M., and Saltiel A.R. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport protein. Am J Physiol Endocrinol Metab 292 (2007) 166-174
35. Abel E.D., Peroni O., Kim J.K., Kim Y.B., Boss O., Hadro E., et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409 (2001) 729-733
36. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116 (2006) 1494-1505
37. Kowalski J., Okopień B., Madej A., Makowiecka K., Zieliński M., Kalina Z., et al. Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and IIb. Int J Clin Pharm Ther 39 (2001) 48-52
38. Kim C.S., Park H.S., Kawada T., Kim J.H., Lim D., Hubbard N.E., et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes 30 (2006) 1347-1355
39. Kowalski J., Okopień B., Madej A., Zieliński M., Belowski D., Kalina Z., et al. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia. Eur J Clin Pharmacol 59 (2003) 189-193
40. Simeoni E., Hoffmann M.M., Winkelman B.R., Ruiz J., Fleury S., Boehm B.O., et al. Association between the A-2518G, polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47 (2004) 1574-1580
41. Sadler D., Mattacks C.A., and Pond C.A. Changes in adipocytes and DCs in lymph node containing adipose depots during and after many weeks of mild inflammation. J Anat 207 (2005) 769-781
42. Bedford P.A., Todorovic V., Westcott E.D., Windsor A.C., English N.R., et al. Adipose tissue of human omentum is a major source of DC, which lose MHC Class II and stimulatory function in Crohn's disease. J Leukoc Biol 80 (2006) 546-554
43. Erol A. Retrograde regulation due to mitochondrial dysfunction may be an important mechanism for carcinogenesis. Med Hypotheses 65 (2005) 525-529